[go: up one dir, main page]

DE10346751A1 - Clot-Lysis-Assay - Google Patents

Clot-Lysis-Assay Download PDF

Info

Publication number
DE10346751A1
DE10346751A1 DE2003146751 DE10346751A DE10346751A1 DE 10346751 A1 DE10346751 A1 DE 10346751A1 DE 2003146751 DE2003146751 DE 2003146751 DE 10346751 A DE10346751 A DE 10346751A DE 10346751 A1 DE10346751 A1 DE 10346751A1
Authority
DE
Germany
Prior art keywords
clot lysis
lysis assay
streptokinase
psac
reteplase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2003146751
Other languages
English (en)
Inventor
Thomas Stief
Harald Renz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philipps-Universitaet Marburg 35037 Marburg De
Original Assignee
Transmit Gesellschaft fuer Technologietransfer mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmit Gesellschaft fuer Technologietransfer mbH filed Critical Transmit Gesellschaft fuer Technologietransfer mbH
Priority to DE2003146751 priority Critical patent/DE10346751A1/de
Priority to PCT/DE2004/002224 priority patent/WO2005033711A2/de
Publication of DE10346751A1 publication Critical patent/DE10346751A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung bezieht sich auf eine neue Methode eines Clot-Lyse-Assays, der zur Untersuchung der Thrombolyse, insbesondere durch Urokinase (u-PA), t-PA, Streptokinase (SK), Plasminogen-Streptokinase-Aktivator-Komplex (PSAC), Reteplase (RP) oder Tenecteplase (TP), verwendet werden kann.
DE2003146751 2003-10-06 2003-10-06 Clot-Lysis-Assay Withdrawn DE10346751A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE2003146751 DE10346751A1 (de) 2003-10-06 2003-10-06 Clot-Lysis-Assay
PCT/DE2004/002224 WO2005033711A2 (de) 2003-10-06 2004-10-05 Clot-lyse-assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2003146751 DE10346751A1 (de) 2003-10-06 2003-10-06 Clot-Lysis-Assay

Publications (1)

Publication Number Publication Date
DE10346751A1 true DE10346751A1 (de) 2005-04-21

Family

ID=34353347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2003146751 Withdrawn DE10346751A1 (de) 2003-10-06 2003-10-06 Clot-Lysis-Assay

Country Status (2)

Country Link
DE (1) DE10346751A1 (de)
WO (1) WO2005033711A2 (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838529A1 (de) * 1988-11-14 1990-05-17 Behringwerke Ag Globaltest zur erfassung der hauptkomponenten des fibrinolysesystems
DE3917949A1 (de) * 1989-05-30 1991-01-24 Schering Ag Neues thrombolytikum
DE19756773A1 (de) * 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
DE19903693A1 (de) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII
US20030017147A1 (en) * 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838529A1 (de) * 1988-11-14 1990-05-17 Behringwerke Ag Globaltest zur erfassung der hauptkomponenten des fibrinolysesystems
DE3917949A1 (de) * 1989-05-30 1991-01-24 Schering Ag Neues thrombolytikum
US20030017147A1 (en) * 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis
DE19756773A1 (de) * 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
DE19903693A1 (de) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENNET,W.F.:High resolution analysis of functional determinants on human tissue-type plasminogen activator. In:J.Biol.Chem.,(1991),266 (8),S.5191-201 *
Datenband PubMed bei NCBI, Adresse www.ncbi.nlm.nih. gov Zusammenfassung zu: RHODES N.P. & WILLIAMS D.F.: Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials.In:Biomaterials (1994),15,(1),S.35-7 (recherchiert am 30.06.2004) *
Datenband PubMed bei NCBI,Adresse www.ncbi.nlm.nih.gov Zusammenf. zu SAKHAROV,D.V.,u.a.:Fibrin-specificity of a *
REED,G.L.,u.a.:Synergistic fibrinolysis:combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin..In:Proc.Natl.Acad. Sci,USA (1990),87,(3),S.1114-8 *

Also Published As

Publication number Publication date
WO2005033711A2 (de) 2005-04-14
WO2005033711A3 (de) 2005-06-02

Similar Documents

Publication Publication Date Title
Lou et al. Performance characteristics of cementitious composites modified with silica fume: A systematic review
Simkhada et al. A novel fibrinolytic protease from Streptomyces sp. CS684
BR112017023444A2 (pt) peça de aço endurecida sob pressão, peça de aço soldada a laser endurecida sob pressão, processo de fabricação de peças de aço e uso de peça
ATE416789T1 (de) Kombinationen für die hcv-behandlung
ATE505312T1 (de) Verfahren zur herstellung eines griffes
ATE485838T1 (de) Oligo- oder polyalkylenglycolgekoppelte thrombininhibitoren
Yang et al. A bi-functional anti-thrombosis protein containing both direct-acting fibrin (ogen) olytic and plasminogen-activating activities
TW200723488A (en) Diagnostic circuit and method therefor
CU23586A1 (es) Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
CL2011000206A1 (es) Composicion biocida que comprende ciprodinil y fluazinam; metodo para controlar enfermedades, en plantas utiles o en material de propagacion, causadas por fitopatogenos (div. sol. n°2602-06).
TW200700057A (en) Alpha ketoamide compounds as cysteine protease inhibitors
MX2022014161A (es) Vacunas contra sars-cov-2.
DE10346751A1 (de) Clot-Lysis-Assay
DE50202661D1 (de) Ionensensitiver feldeffekttransistor und verfahren zum herstellen eines ionensensitiven feldeffekttransistors
NO20034278L (no) Sammensetninger og fremgangsmåter til behandling av HCV- infeksjoner
DE602005018736D1 (de) Wasserzeichenmarkierung eines Computerprogrammcodes mittels äquivalenter mathematischer Ausdrücke
GB0620255D0 (en) Antibody and uses thereof
EA200301271A1 (ru) Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта
DE60217357D1 (de) Verfahren zur bestimmung der wirkungen von botulinum-toxinen
DE60032029D1 (de) Antithrombose agenzien
TW200801015A (en) Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
AR053324A1 (es) Aditivos con contenidos de silicato para tratmientos de pozos y metodos relacionados
AU2021246398A8 (en) Fusion protein suitable for dissolving fibrin clot, and pharmaceutical composition containing said fusion protein
Shende et al. Modeling and analysis of hammer of Impact testing machine: a review
Fan et al. Research on ultrasonic shot peening through numerical simulation

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8127 New person/name/address of the applicant

Owner name: PHILIPPS-UNIVERSITAET MARBURG, 35037 MARBURG, DE

8110 Request for examination paragraph 44
R016 Response to examination communication
R016 Response to examination communication
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee